SLXN - Silexion Therapeutics Corp Forecast, Target Price

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-94.56	Insider Own	5.46%	Shs Outstand	0.31M	Perf Week	0.73%
Market Cap	2.92M	Forward P/E	-	EPS next Y	-20.30	Insider Trans	-28.23%	Shs Float	-	Perf Month	-33.94%
Enterprise Value	2.47M	PEG	-	EPS next Q	-21.20	Inst Own	1.60%	Short Float	-	Perf Quarter	-79.01%
Income	-12.91M	P/S	-	EPS this Y	44.98%	Inst Trans	-	Short Ratio	0.03	Perf Half Y	-88.64%
Sales	0.00M	P/B	2.95	EPS next Y	58.82%	ROA	-200.00%	Short Interest	0.02M	Perf YTD	-85.68%
Book/sh	0.93	P/C	1.20	EPS next 5Y	43.92%	ROE	-897.46%	52W High	223.60 -98.77%	Perf Year	-97.74%
Cash/sh	2.30	P/FCF	-	EPS past 3/5Y	- -38.17%	ROIC	-2381.92%	52W Low	2.31 19.05%	Perf 3Y	-99.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.09% 15.02%	Perf 5Y	-99.98%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	96.81%	Oper. Margin	-	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.00	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	33.19	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.00	EPS Q/Q	77.96%	SMA20	-24.13%	Beta	-0.21	Target Price	33.00
Payout	-	Debt/Eq	6.86	Sales Q/Q	-	SMA50	-46.87%	Rel Volume	0.05	Prev Close	2.73
Employees	14	LT Debt/Eq	0.86	Earnings	May 18 BMO	SMA200	-86.00%	Avg Volume	626.23K	Price	2.75
IPO	Apr 07, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	34.11% -	Trades		Volume	32,649	Change	0.73%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)